Amy DuRoss

Amy is a passionate leader and innovator in the field of personalized medicine. She is currently the President of Cell and Gene Therapies at CSafe Global a leading provider of cold chain shipping solutions for life-saving biologics. In this role she oversees the strategy operations and growth of the company’s cell and gene solutions which enable the safe and efficient delivery of advanced therapies to patients worldwide. Amy is also a Senior Advisor to Frazier Healthcare Partners.